Skip to content
2000
Volume 11, Issue 1
  • ISSN: 2210-6812
  • E-ISSN: 2210-6820

Abstract

Cancer is a leading cause of mortality, and its individual and collective impact is substantial. Conventional chemotherapy utilizes drugs that effectively destroy tumour cells. However, these agents destroy healthy cells along with the tumour cells, leading to many adverse effects, which include hypersensitivity reactions, nephrotoxicity, and neurotoxicity. To minimize these adverse effects, various drug delivery systems (DDSs) have been developed. Among them, nano drug delivery systems are particularly attractive platform. Thus, this review paper explores recent work on targeted delivery; tumour accumulation enhancement and sustained blood circulation using more effective biomaterials to enhance the properties of nanoparticles. Moreover, various target-specific drug delivery mechanisms, such as antibody-mediated delivery as well as the targeting of angiogenesis, mitochondria, and the CD44 receptor, are also explained.

Loading

Article metrics loading...

/content/journals/nanoasi/10.2174/2210681210666200213121156
2021-02-01
2025-09-10
Loading full text...

Full text loading...

/content/journals/nanoasi/10.2174/2210681210666200213121156
Loading

  • Article Type:
    Review Article
Keyword(s): cancer; general principles; nanoparticles; Nanotechnology; targeted delivery; tumour
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test